Modelling Study Quantifies Vaccine Health Impact Across Gavi's Portfolio

A new modelling study published in The Lancet addresses the critical need for robust metrics to guide vaccine selection within Gavi, the Vaccine Alliance's country budgets. As decisions regarding which vaccines to deploy become increasingly significant for national immunisation programmes, the ability to compare the relative health impacts of different vaccines is essential for informed decision-making. This research presents vaccine impact ratios derived from an analysis of 117 countries at the subregional level. These ratios serve as a vital tool to complement existing evidence, thereby supporting more effective planning and prioritisation strategies. By providing a standardized method for comparing vaccine efficacy and impact, the study aims to enhance the efficiency of resource allocation in global health initiatives. The findings are particularly relevant for policymakers and health officials involved in shaping national immunisation agendas, offering data-driven insights to optimize public health outcomes. Ultimately, this work underscores the importance of quantitative analysis in strengthening the strategic framework of international vaccine alliances and ensuring that limited healthcare budgets are utilized to maximize health benefits across diverse populations.